LONDON, UK / ACCESSWIRE / October 12, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Monsanto Co. (NYSE: MON), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=MON, following the Company's reporting of its financial results on October 04, 2017, for the fourth quarter fiscal 2017. The Company's net revenue increased 5% on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on MON. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=MON

Earnings Reviewed

For three months ended August 31, 2017, Monsanto's net revenue increased 5% to $2.69 billion from $2.56 billion in Q4 FY16. The Company's net revenue surpassed analysts' expectations of $2.41 billion.

During FY17, Monsanto's net revenue increased 8.4% to $14.64 billion from $13.50 billion in FY16. The increase was due primarily to record technology adoption for the newest soybean technologies across the Americas and global corn pricing.

During Q4 FY17, the Company's gross profit increased 17.5% to $1.34 billion from $1.14 billion in Q4 FY16. For the reported quarter, the Company's gross margin increased 530 basis points to 49.8% of revenue from 44.5% of revenue in Q4 FY16. For the reported quarter, Monsanto's adjusted gross profit increased 16.5% to $1.34 billion from $1.15 billion in Q4 FY16.

During FY17, Monsanto's gross profit increased 13.1% to $7.94 billion from $7.02 billion in FY16.

During Q4 FY17, Monsanto's selling, general, and administrative (SG&A) expenses decreased 3.7% to $938 million from $975 million in Q4 FY16. During Q4 FY17, the Company's research and development (R&D) expenses increased 4.2% to $439 million from $421 million in the same period last year.

For the reported quarter, Monsanto's operating loss was $63 million compared to operating loss of $265 million in Q4 FY16. During FY17, Monsanto's operating income increased 34.8% to $3.21 billion from $2.38 billion in FY16.

During Q4 FY17, Monsanto's net income was $20 million compared to net loss of $191 million in Q4 FY16. For the reported quarter, the Company's adjusted net income increased 173.3% to $82 million on a y-o-y basis from $30 million in Q4 FY16. During Q4 FY17, Monsanto's diluted EPS was positive $0.05 compared to negative diluted EPS of $0.44 in Q4 FY16. For the reported quarter, the Company's adjusted diluted EPS increased 185.7% to $0.20 on a y-o-y basis from $0.07 in Q4 FY16. Adjusted diluted EPS surpassed analysts' expectations of negative $0.38.

During FY17, Monsanto's net income increased 68.6% to $2.26 billion from $1.34 billion in FY16. During FY17, the Company's adjusted net income increased 22% to $2.44 billion on a y-o-y basis from $2.00 billion in FY16. During FY17, Monsanto's diluted EPS increased 70.2% to $5.09 on a y-o-y basis from $2.99 in FY16. During FY17, the Company's adjusted diluted EPS increased 22.7% to $5.50 on a y-o-y basis from $4.48 in FY16.

Monsanto's Segment Details

Seeds and Genomics - During Q4 FY17, the Seeds and Genomics segment's net revenue increased 11.4% to $1.75 billion from $1.57 billion in Q4 FY16. For the reported quarter, the segment's gross profit increased 27.7% to $1.11 billion from $869 million in Q4 FY16. The increase was due to penetration of the Company's latest soybean and cotton technologies and continued adoption of newest corn hybrids around the globe. For the reported quarter, the segment's earnings before interest and tax (EBIT) was negative $123 million compared to positive $34 million in Q4 FY16.

Agricultural Productivity - During Q4 FY17, the Agricultural Productivity segment's net revenue decreased 5.8% to $939 million from $997 million in Q4 FY16. For the reported quarter, the segment's gross profit decreased 15.6% to $227 million from $269 million in Q4 FY16. For the reported quarter, the segment's EBIT was positive $61 million compared to negative $137 million in Q4 FY16.

Balance Sheet

As on August 31, 2017, Monsanto's cash and cash equivalents increased 10.7% to $1.86 billion from $1.68 billion in Q4 FY16.

During Q4 FY17, the Company's net trade receivables increased 11.9% to $2.16 billion from $1.93 billion in Q4 FY16.

For the reported quarter, Monsanto's net inventory increased 3% to $3.34 billion from $3.24 billion in Q4 FY16.

During Q4 FY17, the Company's accounts payable increased 5.9% to $1.07 billion from $1.01 billion in Q4 FY16.

During FY17, the Company's cash provided by operating activities increased 24.7% to $3.23 billion from $2.59 billion in FY16.

During FY17, the Company's free cash flow increased 19.1% to $1.99 billion from $1.67 billion in FY16.

Stock Performance

Monsanto's share price finished yesterday's trading session at $119.80, slightly advancing 0.21%. A total volume of 1.54 million shares have exchanged hands. The Company's stock price rallied 2.85% in the last three months, 3.04% in the past six months, and 15.94% in the previous twelve months. Additionally, the stock surged 13.87% since the start of the year. Shares of the Company have a PE ratio of 23.61 and have a dividend yield of 1.80%. The stock currently has a market cap of $52.58 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily